MedPath

Effect of Home Blood Pressure Telemonitoring on hypertension control rate anddrug adherence in Kenya: an interventional study (HBPT-K)

Phase 1
Conditions
Circulatory System
Nutritional, Metabolic, Endocrine
Cardiology
Registration Number
PACTR202408912454189
Lead Sponsor
uscii App
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Age =18 years
- Confirmed hypertension with BP>140/90 mmHg
- Own or have access to a smartphone with internet access throughout the study
period
- Able to provide written informed consent prior to participation in the study

Exclusion Criteria

- Persistent atrial fibrillation as indicated in the health record
- Pregnant or planning to become pregnant during the study period
- Severe kidney disease, defined as estimated glomerular filtration rate <30 per
1.73 m2 or currently on renal replacement therapy (i.e., hemodialysis or
peritoneal dialysis)
- Recent cardiovascular event (ischemic stroke, transient ischemic attack,
myocardial infarction, coronary artery bypass grafting) in the past 3 months
- Diagnosis of dementia or psychosis as indicated in the health record
- Life expectancy <1 year, for instance in terminal cancer or NYHA III or IV
heart failure
- Individuals requiring BP monitor cuff size larger than 42cm

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HBPT will improve hypertension control rates (% below &lt;140/90mmHg, as measured by the SPRINT protocol) at 6 months as compared with historical nationwide hypertension control rates.
Secondary Outcome Measures
NameTimeMethod
HBPT will improve drug adherence (as measured with the MARS-5 tool) as compared with historical nationwide drug adherence data.;Digital application of Kenya’s national cardiovascular disease guidelines will lead to improved guideline adherence as measure by ‘guideline-based prescriptions’ compared with baseline.;Patient satisfaction in the HBPT program will be high based on TUQ and MAUQ questionnaires (overall median &gt;5, scale 1 to 7)
© Copyright 2025. All Rights Reserved by MedPath